Trojan™ Premium Latex Condoms Sensitivity Ultra Thin Armor™ 00022600927426Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00022600927426), received between Jul 19, 2026 and Jul 19, 2026 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjuryJul 19, 2026Adverse Event Without Identified Device or Use Problem

  A CONSUMER FROM THE UNITED STATES REPORTED VIA AN ONLINE REVIEW ON (B)(6) 2026 THAT, FOLLOWING USE OF TROJAN ULTRA-THIN SPERMICIDAL CONDOMS (12 COUNT), THEY EXPERIENCED URETHRAL INFLAMMATION AND GENITAL BLEEDING. NO FURTHER INFORMATION WAS PROVIDED TO PERMIT MEDICAL ASSESSMENT OR VERIFICATION OF THE REPORTED EVENT. THE REPORTER REPORTED USING TROJAN ULTRA-THIN CONDOMS. AS REPORTED BY THE CONSUMER, FOLLOWING USE OF THE CONDOM, THE CONSUMER EXPERIENCED URETHRAL IRRITATION/INFLAMMATION, BLEEDING FROM THE GENITAL AREA, SEVERE PAIN, MULTIPLE HOSPITAL VISITS, AND MULTIPLE CATHETERIZATIONS. THE CONSUMER ATTRIBUTED THE EVENT TO THE SPERMICIDE CONTAINED IN THE PRODUCT AND STATED THEY DO NOT HAVE A LATEX ALLERGY. NO ADDITIONAL INFORMATION, MEDICAL RECORDS, PHYSICIAN DIAGNOSIS, TREATMENT DETAILS, OR PRODUCT LOT INFORMATION WERE AVAILABLE TO VERIFY THE REPORTED EVENT OR TREATMENT. HOWEVER, DUE TO THE REPORTED NEED FOR MEDICAL INTERVENTION, INCLUDING MULTIPLE CATHETERIZATIONS AND HOSPITAL VISITS, THE EVENT WAS ASSESSED AS A SERIOUS INJURY AND REPORTED IN AN ABUNDANCE OF CAUTION.

  Patient problems: Genital Bleeding; Inflammation

  MAUDE report 25867975 ↗